{
  "questions": [
    {
      "type": "factoid",
      "id": "64403ab057b1c7a31500004d",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "two"
        ],
        [
          "two suprachoroidal injections of CLS-TA at 0 and 12 weeks"
        ],
        [
          "two suprachoroidal injections"
        ],
        [
          "two suprachoroidal"
        ],
        [
          "two suprachoroidal injections of CLS-TA at 0 and 12 weeks with follow up lasting 24 weeks"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6411b678201352f04a000036",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "acquired"
        ],
        [
          "autosomal dominant"
        ],
        [
          "autosomal dominant mode of inheritance"
        ],
        [
          "Congenital"
        ],
        [
          "acquired prosopagnosia"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "643bc8f957b1c7a31500002b",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "Promoters"
        ],
        [
          "Promoters mark the start of every transcript and are an important class of regulatory elements"
        ],
        [
          "A promoter is a short region of DNA (100-1,000 bp)"
        ],
        [
          "directly upstream or at the 5' end of the transcription initiation site"
        ],
        [
          "5' end of the transcription initiation site"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "64403be357b1c7a31500004e",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "24 weeks"
        ],
        [
          "24"
        ],
        [
          "0 and 12 weeks with follow up lasting 24 weeks"
        ],
        [
          "12 weeks with follow up lasting 24 weeks"
        ],
        [
          "weeks"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6440396957b1c7a31500004b",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "Suprachoroidal"
        ],
        [
          "Suprachoroidal delivery"
        ],
        [
          "Suprachoroidal (SC)"
        ],
        [
          "Microinjector"
        ],
        [
          "suprachoroidal space (SCS\u00ae)"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6431708a57b1c7a315000017",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "cardiomyocytes"
        ],
        [
          "miR-145"
        ],
        [
          "T1AM"
        ],
        [
          "T1AM on cardiomyocytes"
        ],
        [
          "145"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "640f8641201352f04a00002c",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "eyes"
        ],
        [
          "subscleral"
        ],
        [
          "P"
        ],
        [
          "trabeculotomy"
        ],
        [
          "3 Schlemm's Canal Microinvasive Glaucoma Surgery Devices"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "644009c557b1c7a315000041",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "autosomal recessive"
        ],
        [
          "recessive"
        ],
        [
          "autosomal recess"
        ],
        [
          "auto"
        ],
        [
          "Friedreich's Ataxia (FRDA) is an autosomal recessive"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "64371a4257b1c7a315000029",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "operons"
        ],
        [
          "Clustering of functionally related genes in operons"
        ],
        [
          "polycistronic messages (operons)"
        ],
        [
          "polycistronic messages"
        ],
        [
          "Clustering of functionally related genes in operon"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6440377c57b1c7a315000049",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "triamcinolone acetonide"
        ],
        [
          "triamcinolone"
        ],
        [
          "acetonide"
        ],
        [
          "CLS-TA, a triamcinolone acetonide"
        ],
        [
          "CLS-TA, a triamcinolone"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6441057657b1c7a315000052",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "FLACC"
        ],
        [
          "FLACC and COMFORT"
        ],
        [
          "Wong-Baker Faces Pain Rating Scale"
        ],
        [
          "FLACC-r"
        ],
        [
          "Wong-Baker Faces"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "64257c9c690f196b5100004b",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "early detection of drug's hepatotoxicity in clinical drug development"
        ],
        [
          "phenotype-based drug-induced liver injury causality assessment tool"
        ],
        [
          "drug-specific liver injury phenotypes"
        ],
        [
          "DILI causality assessment tool"
        ],
        [
          "liver injury phenotypes"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6429e85e57b1c7a315000009",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "riboswitches"
        ],
        [
          "riboswitches are typically located in noncoding regions of mRNA"
        ],
        [
          "Metabolite-sensing mRNAs, or \"riboswitches"
        ],
        [
          "Riboswitch"
        ],
        [
          "riboswitches might be representatives of an ancient form of genetic control"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6440393157b1c7a31500004a",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "2021"
        ],
        [
          "202"
        ],
        [
          "the 2021"
        ],
        [
          "2021 FDA approval of CLS-TA"
        ],
        [
          "after the 2021"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6415b3b4690f196b51000009",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "yellow light"
        ],
        [
          "yellow"
        ],
        [
          "light"
        ],
        [
          "millisecond-timescale pulses of yellow light"
        ],
        [
          "millisecond-timescale pulses of yellow"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6429fad757b1c7a31500000e",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "TATA box"
        ],
        [
          "TATA\" box"
        ],
        [
          "TATAWAWR"
        ],
        [
          "TFIID"
        ],
        [
          "TATA-like element and their promoters are generally AT-rich;"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "64402e7757b1c7a315000044",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "9"
        ],
        [
          "Nineteen"
        ],
        [
          "Nineteen patients enrolled in the trial, and 18"
        ],
        [
          "9 subjects"
        ],
        [
          "Nine"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "64425ce357b1c7a315000059",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "1 in 20000"
        ],
        [
          "1:8000"
        ],
        [
          "8000"
        ],
        [
          "20000"
        ],
        [
          "1:8000 incidence"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "63f581e933942b094c000007",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "spinal muscular atrophy"
        ],
        [
          "SMA"
        ],
        [
          "motor neurons. Major advances and developments in SMA"
        ],
        [
          "Major advances and developments in SMA"
        ],
        [
          "Type 1 or 2 spinal muscular atrophy"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6431f7de57b1c7a31500001b",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "frataxin"
        ],
        [
          "frataxin (FXN) gene"
        ],
        [
          "f"
        ],
        [
          "frataxin in whole blood from healthy controls and homozygous FRDA"
        ],
        [
          "frataxin (FXN)"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "643f9eeb57b1c7a31500003c",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "19.7"
        ],
        [
          "1:5,000 live male births"
        ],
        [
          "1:5,000"
        ],
        [
          "The cumulative incidence of disease was 19.7"
        ],
        [
          "19.7 per 100,000 male live births"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6415c252690f196b51000011",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "bladder cancer"
        ],
        [
          "Cancer"
        ],
        [
          "Non-muscle Invasive Bladder Cancer"
        ],
        [
          "Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder Cancer"
        ],
        [
          "Treatment of Non-muscle Invasive Bladder Cancer"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "63eeed0af36125a426000007",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "Multiple Myeloma"
        ],
        [
          "myeloma"
        ],
        [
          "Multiple"
        ],
        [
          "Teclistamab in Relapsed or Refractory Multiple Myeloma"
        ],
        [
          "Relapsed or Refractory Multiple Myeloma"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "63f03ea0f36125a426000020",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "Clostridioides difficile"
        ],
        [
          "C. difficile"
        ],
        [
          "rCDI"
        ],
        [
          "SER-109, an investigational oral microbiome therapeutic, was superior to placebo in reducing rCDI"
        ],
        [
          "reducing rCDI"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "64179113690f196b5100002e",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "Xp21"
        ],
        [
          "Xp21 chromosome locus"
        ],
        [
          "Xp21)"
        ],
        [
          "X"
        ],
        [
          "X chromosome (Xp21)"
        ]
      ]
    },
    {
      "type": "factoid",
      "id": "6415c9e9690f196b51000018",
      "ideal_answer": [
        "Dummy"
      ],
      "exact_answer": [
        [
          "mTNBC"
        ],
        [
          "m"
        ],
        [
          "PD-L1-positive mTNBC"
        ],
        [
          "positive mTNBC"
        ],
        [
          "mTNBC, as the FDA recently approved atezolizumab (Tecentriq) and pembrolizumab"
        ]
      ]
    }
  ]
}